Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;68(11):1561-1564.
doi: 10.4187/respcare.10718. Epub 2023 May 30.

A New Dynamic Slow-Flow Esophageal Balloon Pressure-Volume Curve Calibration Method to Assess Transpulmonary Pressure Monitoring

Affiliations

A New Dynamic Slow-Flow Esophageal Balloon Pressure-Volume Curve Calibration Method to Assess Transpulmonary Pressure Monitoring

Arnaud Mari et al. Respir Care. 2023 Nov.
No abstract available

Keywords: esophageal air-filled catheter calibration; esophageal pressure; transpulmonary pressure monitoring.

PubMed Disclaimer

Conflict of interest statement

The authors have disclosed no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Synopsis of experimental protocol. Fig 1A: Set-up of experimental protocol for high-resolution dynamic esophageal balloon pressure-volume (PV) curve. Esophageal balloon was filled with air with a piloted syringe (filling balloon at rate of 100 mL/h, ie, 1.67 mL/min). Fig 1B: Air-filled esophageal balloon PV curve built with a continuous slow-flow inflation sequence (and subsequent occlusion test [OT] maneuver): recording and graphical/computerized analysis. Fig 1C–D: Continuous slow-flow PV curve graphics focus on VbestXP: recording and graphical/computerized analysis. C: Volume balloon with maximal Pes tidal variation. D: Analytics of dynamic PV curve leading to an estimate of VbestXP = 1.37 mL. Fig 1E–F: Detailed description focused on OT sequence. E: Computation of OT (as ΔPes/ΔPaw ratio) at each volume step (see text for detailed description of OT sequence). F: Maximal ratio defining VbestOT (top green triangle): here VbestOT = 1.5 mL, which closely match with VbestXP (1.37 mL) estimated by our experimental method (panel D). PV = pressure-volume; Pes = esophageal pressure; esp = expiratory; Paw = airway pressure; OT = occlusion test.
Fig. 2.
Fig. 2.
Reliability of experimental data versus reference. A: Scatterplot of the VbestOT versus VbestXP relationship (dots) superimposed with its associated linear fit (dashed line). B: Scatterplot of the Pes,expOT versus Pes,expXP relationship (dots) superimposed with its associated linear fit (dashed line). C: Scatterplot of the Pes,expOT versus Pes,expV4 relationship (dots) superimposed with its associated linear fit (dashed line). Linear coefficients, intercepts, and R2 statistics are displayed for each panel. V = volume; OT = occlusion test; XP = experimental slow-flow method variables; Pes = esophageal pressure; exp = expiratory; V4 = 4 mL volume.

References

    1. Mauri T, Yoshida T, Bellani G, Goligher EC, Carteaux G, Rittayamai R, et al. ; PLeUral pressure working Group (PLUG—Acute Respiratory Failure section of the European Society of Intensive Care Medicine). Esophageal and transpulmonary pressure in the clinical setting: meaning, usefulness, and perspectives. Intensive Care Med 2016;42(9):1360–1373. - PubMed
    1. Gattinoni L, Giosa L, Bonifazi M, Pasticci I, Busana M, Macri M, et al. . Targeting transpulmonary pressure to prevent ventilator-induced lung injury. Expert Rev Respir Med 2019;13(8):737–746. - PubMed
    1. Pham T, Telias I, Beitler JR. Esophageal manometry. Respir Care 2020;65(6):772–792. - PMC - PubMed
    1. Grasso S, Terragni P, Birocco A, Urbino R, Del Sorbo L, Filippini C, et al. . ECMO criteria for influenza A (H1N1)–associated ARDS: role of the transpulmonary pressure. Intensive Care Med 2012;38(3):395–403. - PubMed
    1. Sarge T, Baedorf-Kassis E, Banner-Goodspeed V, Novack V, Loring SH, Gong MN, et al. ; EPVent-2 Study Group. Effect of esophageal pressure–guided positive end-expiratory pressure on survival from acute respiratory distress syndrome: a risk-based and mechanistic re-analysis of the EPVent-2 trial. Am J Respir Crit Care Med 2021;204(10):1153–1163. - PMC - PubMed

LinkOut - more resources